NO972525L
Benzimidazole derivatives with antihistaminic activity
Abstract
Where R1 is hydrogen, or short-chain hydrocarbon-based, such as methyl, ethyl, isopropyl, cyclopropyl, or vinyl, R2 is selected from the CH2OH, COOH, COOR3, and 4,4-II n-oxazoline in base groups, R3 as already mentioned short chain alkyl such as methyl, ethyl, etc. Also describes the method of preparation of such compounds, these compounds have high H1 antihistamines and anti-allergy activity and avoid the role of the central nervous and cardiovascular systems.
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
48 members in 27 offices
Priority claims1
| Document | Office | Kind | Date |
|---|---|---|---|
| 9601236 | Spain | A |
Members48
| Document | Office | Kind | |
|---|---|---|---|
| NO972525D0 | Norway | D0 | |
| HU9700997D0 | Hungary | D0 | |
| CA2206754A1 | Canada | A1 | |
| NO972525LThis record | Norway | L | |
| PL320358A1 | Poland | A1 | |
| AU2467297A | Australia | A | |
| CZ172397A3 | Czechia | A3 | |
| TR199700464A2 | Türkiye | A2 | |
| TR199700464A3 | Türkiye | A3 | |
| ZA974893B | South Africa | B | |
| EP0818454A1 | European Patent Office (EPO) | A1 | |
| JPH1059961A | Japan | A | |
| CN1176964A | China | A | |
| HRP970307A2 | Croatia | A2 | |
| ES2124167A1 | Spain | A1 | |
| US5877187A | United States of America | A | |
| ES2124167B1 | Spain | B1 | |
| HU9700997A1 | Hungary | A1 | |
| HUP9700997A1 | Hungary | A1 | |
| AR008386A1 | Argentina | A1 | |
| AU725700B2 | Australia | B2 | |
| TW438794B | Taiwan Province of China | B | |
| IN186319B | India | B | |
| CZ289278B6 | Czechia | B6 | |
| HRP970307B1 | Croatia | B1 | |
| RU2182150C2 | Russian Federation | C2 | |
| NO313195B1 | Norway | B1 | |
| CN1105716C | China | C | |
| EP0818454B1 | European Patent Office (EPO) | B1 | |
| AT264317T | Austria | T | |
| ATE264317T1 | Austria | T1 | |
| DE69728608D1 | Germany | D1 | |
| DK0818454T3 | Denmark | T3 | |
| BR9703276A | Brazil | A | |
| PT818454E | Portugal | E | |
| SI0818454T1 | Slovenia | T1 | |
| DE69728608T2 | Germany | T2 | |
| PL188908B1 | Poland | B1 | |
| MXPA97004127A | Mexico | A | |
| CA2206754C | Canada | C | |
| JP4218991B2 | Japan | B2 | |
| LU91798I2 | Luxembourg | I2 | |
| NO2011008I1 | Norway | I1 | |
| DE122011000006I1 | Germany | I1 | |
| FR11C0023I1 | France | I1 | |
| HU227598B1 | Hungary | B1 | |
| FR11C0023I2 | France | I2 | |
| NO2011008I2 | Norway | I2 |
4 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Expiry of an spcSPCX | SPCX | |
| Patent expiredExpiredMK1K | MK1K | |
| Granted supplementary protection certificateGrantedSPCG | SPCG | |
| Filing of supplementary protection certificateSPCF | SPCF |
Numbers
- Application
- 972525
Titles2
- English
- New benzimidazole derivatives with antihistamine activity
- Norwegian
- Nye benzimidazolderivater med antihistaminaktivitet
Classification
- CPC, 4
- C07D401/04
- A61P11/06
- A61P37/08
- A61P43/00
- IPC, 12
- A61K31 4184
- A61K31 4427
- A61K31 445
- C07D403 04
- A61P37 08
- A61P43 00
- C07D235 04
- C07D235 06
- C07D401 04
- C07D413 14
- H02B11 04
- H02B11 24